Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levomilnacipran for Smoking Cessation
NCT02265367Completed
- Sponsor
- University of Minnesota
- Start
- Jan 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levomilnacipran in Tobacco Use Disorder (TUD), sponsored by University of Minnesota. Primary endpoint: Percent of Days of Confirmed Abstinence at 5 days. Started Jan 2015; status: completed.
02
Drugs
levomilnacipran
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02265367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02265367.